CALL US NOW 0207 939 0780
PLEASE DONATE

BLOG

OUR BLOG

UK launches FibCLOT®▼ LFB’s human fibrinogen concentrate

LFB Biopharmaceuticals announced today the UK launch of FibCLOT, its human fibrinogen concentrate. This follows the granting of a UK Marketing Authorisation in April 2016, after a decentralised application to the Regulatory Authorities in Europe, and offers increased therapeutic choices for affected patients. FibCLOT® is indicated for the treatment and perioperative

Read More

Direct-acting Antiviral (DAA) treatment for Hepatitis C risks Hepatitis B reactivation

New guidance from the Medicines and Healthcare products Regulatory Agency (MHRA) advises that all hepatitis C patients should be screened for hepatitis B before starting treatment with new Direct-acting Antivirals (DAAs). If patients are infected with both viruses this does not preclude treatment but this should be monitored and managed.

Read More

Westminster Justice Summit

The Haemophilia Society attended the Westminster Justice Summit today, hosted by Andy Burnham MP. At the event representatives from a large number of justice campaigns, including campaigners on contaminated blood shared their situations and challenges with the group. In his comments, Andy Burnham said there was a need to rebalance

Read More

The winter edition of the EHC newsletter is out now

The latest newsletter from the European Haemophilia Consortium is now available on their website. For the final issue of their comprehensive care and haemophilia spotlight of the year, they interview Prof Geoffrey Dusheiko, an emeritus professor of medicine at the Royal Free Hospital (London) and the University College London School

Read More